SERG Technologies

The company develops a proprietary sensing suite and AI algorithms to objectively quantify Parkinsonian motor symptoms such as tremor, bradykinesia, and rigidity. Their primary product, StimSense, is an automated assessment tool designed to accelerate Deep Brain Stimulation (DBS) programming by providing instant feedback and analytics to clinicians. The platform utilizes wearable sensors combining motion capture and muscle activity monitoring to assist in medication response tracking and personalized therapy planning for patients.